Fax: (011) 4623492389
Multifocal breast cancer documented in large-format histology sections
Long-term follow-up results by molecular phenotypes
Article first published online: 27 DEC 2012
Copyright © 2012 American Cancer Society
Volume 119, Issue 6, pages 1132–1139, 15 March 2013
How to Cite
Pekar, G., Hofmeyer, S., Tabár, L., Tarján, M., Chen, T. H.-H., Yen, A. M.-F., Chiu, S. Y.-H., Hellberg, D., Gere, M. and Tot, T. (2013), Multifocal breast cancer documented in large-format histology sections. Cancer, 119: 1132–1139. doi: 10.1002/cncr.27877
- Issue published online: 4 MAR 2013
- Article first published online: 27 DEC 2012
- Manuscript Accepted: 11 SEP 2012
- Manuscript Revised: 6 SEP 2012
- Manuscript Received: 9 AUG 2012
- breast cancer;
- molecular phenotypes;
The prognostic significance of molecular phenotype in breast cancer is well established in the literature. Recent studies have demonstrated that subgross lesion distribution (unifocal, multifocal, and diffuse) and disease extent also carry prognostic significance in this disease. However, the correlation of molecular phenotypes with subgross parameters has not yet been investigated in detail.
In total, 444 consecutive invasive breast cancers that were documented in large-format histology slides and worked up with detailed radiologic-pathologic correlation were sampled into tissue microarray blocks and stained immunohistochemically to delineate the molecular subtypes.
Diffuse or multifocal distribution of the invasive component of breast carcinomas in this series was associated with a 4.14-fold respectively 2.75-fold risk of cancer-related death compared with unifocal tumors irrespective of molecular phenotype. Patients who had human epidermal growth factor receptor 2 (HER2)-positive cancers; estrogen receptor-negative, progesterone receptor-negative, and HER2-negative (triple-negative) cancers; or basal-like cancers had a 2.18-fold, 2.33-fold, and 4.07-fold risk of dying of disease, respectively, compared with patients who had luminal A carcinomas. Unifocal luminal A, HER2-positive, and basal-like cancers were associated with significantly better long-term survival outcomes than their multifocal or diffuse counterparts; luminal B and triple-negative tumors also had the same tendency. In multivariate analysis, patient age, tumor size category, lymph node status, lesion distribution, and molecular phenotypes remained significant.
Multifocality and diffuse distribution of the invasive component were associated with significantly poorer survival in women with breast carcinomas compared with unifocal disease in patients with luminal A, HER2 type, and basal-like cancers. Molecular classification of breast cancer is a powerful tool but gains in power when combined with conventional and subgross morphologic parameters. Cancer 2013. © 2013 American Cancer Society.